A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
Virtual Incision performs $18m funding procedure
The surgical robot spinout from University of Nebraska will use the series B financing, co-led by SinoPharm, to support it through its application for market clearance.
Remynd secures licence agreement
Remynd could receive as much as $413m from healthcare firm Novo Nordisk if its ReS39 diabetes treatment is proven to be effective.
Genequine sells therapy for up to $64m
Flexion will pay an undisclosed up-front sum for Genequine’s arthritis therapy, which is currently in pre-clinical development.
Relay completes $63m series B leg
GV has joined the investors in oncology treatment develolper Relay Therapeutics, which has now raised $120m altogether.
Pionyr institutes $62m series B
NEA has led a series B round for cancer treatment developer Pionyr Immunotherapeutics, co-founded by researchers from UC San Francisco and University of Toronto.
Enpulsion powers up $1.4m investment
The spinout from University of Applied Sciences Wiener Neustadt has obtained capital from AWS Seedfinancing, a program operated by Austria’s federal development bank.
The Warwick spinout has received $5.1m in capital from investors such as Mercia Technologies to fund commercialisation of a transdermal ibuprofen patch.
GenXComm connects to series A investors
UT Horizon Fund has returned for a $7m series A for GenXComm, having also contributed to a $1.5m seed round in June this year.
The company is working on treatments for breast cancer and solid tumours, based on research at University of Toronto and the Centre for the Commercialization of Antibodies and Biologics.
Spirochem synthesises investment
ETH Zurich spinout Spirochem has raised cash to accelerate its sales activities and boost productivity.
Existing shareholders have provided additional funding to Abingdon Health, which is developing a test for multiple myeloma.
Carbon Air breathes in $850,000
University of Salford spinout Carbon Air has closed a funding round led by Mercia Fund Managers.
TearSolutions eyes $8.5m series B
The ocular biotech spinout was has received cash from backers including the VTC Innovation Fund as it prepares to take its dry eye syndrome treatment through clinical testing.
Multiwave Innovation scans MRI licence
Satt Sud-Est has licensed technology relating to metamaterial-based antennae for very powerful MRI scanners to Multiwave Innovation.
VTT spinout TactoTek has attracted $5.9m in funding from Ascend Capital Partners.
Fusion Antibodies amps up for IPO
Queen’s University spinout Fusion Antibodies is targeting $7.4m in proceeds in an IPO that will provide an exit to Qubis and Invest NI.
Cambridge shows off Intellegens
The artificial intelligence developer has secured seed capital of undisclosed size to commercialise its AI-based neural network platform.
Mirriad to insert shares into Aim
University of Surrey in-video advertising spinout Mirriad is set to raise $35m in an initial public offering at a market cap of $84.4m.
Lab150 – a new paradigm in drug discovery
The initiative, launched by Mars Innovation and Evotec in September 2017, seeks to bridge academic research, translation and commercialisation.
UM Ventures launches Baltimore Fund
University of Maryland’s tech transfer office is set to form a fund that will invest in local university-linked startups.
Imperial and Tsinghua seed $300,000 exchange fund
The vehicle will support small-scale experiments and prototypes and give researchers linked with both institutions the opportunity to exchange ideas.


